Cargando…

Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function

BACKGROUND: To calculate the individualized fraction regime (IFR) in stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC) patients using the uncomplicated tumor control probability (UTCP, P(+)) function. METHODS: Thirty-three patients with peripheral lung cancer or lung metas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Jia-Yang, Lin, Pei-Xian, Huang, Bao-Tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587287/ https://www.ncbi.nlm.nih.gov/pubmed/31221159 http://dx.doi.org/10.1186/s13014-019-1318-9

Ejemplares similares

Comparison of Three Radiobiological Models in Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer
por: Lu, Jia-Yang, et al.
Publicado: (2019)

Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy
por: Huang, Bao-Tian, et al.
Publicado: (2015)

Monitor unit optimization in stereotactic body radiotherapy for small peripheral non-small cell lung cancer patients
por: Huang, Bao-Tian, et al.
Publicado: (2015)

Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer
por: Huang, Bao-tian, et al.
Publicado: (2016)

Comparative Analysis of Local Control Prediction Using Different Biophysical Models for Non-Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy
por: Huang, Bao-Tian, et al.
Publicado: (2017)

Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
por: Kalinauskaite, Goda G., et al.
Publicado: (2020)

Individualized Fraction Regimen of SBRT Patients With Non-Small Cell Lung Cancer Based on Uncomplicated and Cancer-Free Control Probability
por: Feng, Ai-Hui, et al.
Publicado: (2021)

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)

Analysis of Hepatocellular Carcinoma Stereotactic Body Radiation Therapy Dose Prescription Method Using Uncomplicated Tumor Control Probability Model
por: Cheung, Michael L.M., et al.
Publicado: (2021)

Doses, fractionations, constraints for stereotactic radiotherapy
por: Borghesi, Simona, et al.
Publicado: (2022)

Comparison of Two RapidArc Delivery Strategies in Stereotactic Body Radiotherapy of Peripheral Lung Cancer with Flattening Filter Free Beams
por: Huang, Bao-Tian, et al.
Publicado: (2015)

Developments in Stereotactic Body Radiotherapy
por: Haridass, Anoop
Publicado: (2018)

Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas
por: Elhateer, H., et al.
Publicado: (2008)

Fractionated stereotactic radiotherapy for pediatric patients with retinoblastoma
por: Higgins, Patrick D., et al.
Publicado: (2006)

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
por: Vasudevan, Harish N., et al.
Publicado: (2017)

The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy
por: Shibamoto, Yuta, et al.
Publicado: (2020)

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
por: Sun, Hui, et al.
Publicado: (2023)

Prostate stereotactic body radiotherapy: quantifying intra-fraction motion and calculating margins using the new BIR geometric uncertainties in daily online IGRT recommendations
por: McNeice, Joseph M, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy for Small Lung Tumors in the University of Tokyo Hospital
por: Yamashita, Hideomi, et al.
Publicado: (2014)

Different fractionation regimes in palliative thoracic radiotherapy: Some facets
por: Sharma, Mukesh, et al.
Publicado: (2015)

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer
por: Zarębska, Izabela, et al.
Publicado: (2023)

Stereotactic radiotherapy of the prostate: fractionation and utilization in the United States
por: P. Weiner, Joseph, et al.
Publicado: (2017)

Effective salvage of recurrent craniopharyngioma with fractionated stereotactic radiotherapy
por: Burgess, Laura, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for Prostate Cancer
por: Parikh, Neil R., et al.
Publicado: (2020)

Accuracy analysis of different dose calculation algorithms for locally advanced pancreatic cancer stereotactic body radiotherapy
por: Song, Yongchun, et al.
Publicado: (2023)

PSMA-PET/CT-Based Stereotactic Body Radiotherapy (SBRT) in the Treatment of Uncomplicated Non-Spinal Bone Oligometastases from Prostate Cancer
por: Pastorello, Edoardo, et al.
Publicado: (2023)

Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability
por: Lindblom, Emely, et al.
Publicado: (2014)

Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review
por: Gong, Yining, et al.
Publicado: (2019)

Residual intra-fraction error in robotic spinal stereotactic body radiotherapy without immobilization devices
por: Rossi, Eleonora, et al.
Publicado: (2020)

Optimized workflow to minimise intra-fractional motion during stereotactic body radiotherapy of spinal metastases
por: vanNiekerk, W.M., et al.
Publicado: (2022)

Stereotactic ablative body radiotherapy versus conventionally fractionated radiotherapy for early stage large cell neuroendocrine carcinoma of the lung
por: Wegner, Rodney E, et al.
Publicado: (2020)

Fractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma
por: Liu, Feng, et al.
Publicado: (2013)

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
por: Wujanto, Caryn, et al.
Publicado: (2019)

Clinical applicability of biologically effective dose calculation for spinal cord in fractionated spine stereotactic body radiation therapy
por: Lee, Seung Heon, et al.
Publicado: (2015)

Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre
por: Peters, Cedric, et al.
Publicado: (2021)

Independent calculation‐based verification of volumetric‐modulated arc therapy–stereotactic body radiotherapy plans for lung cancer
por: Ono, Tomohiro, et al.
Publicado: (2020)

Development of an independent MU calculation software for radiotherapy treatments with stereotactic cones
por: Campos, Guilherme Filipe Pinto, et al.
Publicado: (2022)

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases
por: Shen, Yuxin, et al.
Publicado: (2021)

Stereotactic body radiotherapy optimization to reduce the risk of carotid blowout syndrome using normal tissue complication probability objectives
por: Szalkowski, Gregory, et al.
Publicado: (2022)

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer
por: Wang, Shih-Chang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kcu9oi9cp223l2dc632lttgo02